Royal Bank Of Canada Imv Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.47 - $0.75 $31 - $51	68 Added 0.07%	96,131 $51,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.45 $834 - $2,161	-1,491 Reduced 1.53%	96,063 $63,000
Q1 2022 May 16, 2022	BUY	$1.07 - $1.5 $1,746 - $2,448	1,632 Added 1.7%	97,554 $137,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.78 $1,454 - $2,121	1,192 Added 1.26%	95,922 $117,000
Q3 2021 Nov 15, 2021	SELL	$1.35 - $2.16 $4,861 - $7,778	-3,601 Reduced 3.66%	94,730 $158,000
Q2 2021 Aug 16, 2021	BUY	$2.12 - $3.24 $208,461 - $318,592	98,331 New	98,331 $214,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.